Hangzhou, China · Founded 2020 · Privately Held (backing)
Provider and developer of biological proteins used as medications. JHM Biopharma is based in Hangzhou, China and was founded in 2020. Its last reported valuation was $160 million in May 2024. It has raised $84.8 million.
Last reported valuation
$159.7M
Oct 2026
Priced at
—
Total raised
$84.8M
Last round
—
Team — not yet on record
No current team members for JHM Biopharma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of JHM Biopharma with a free account
·The complete investor list: 13 names
·Watch JHM Biopharma: the Monday email on marks, rounds and moves
